{"id":972564,"date":"2026-06-16T08:33:50","date_gmt":"2026-06-16T12:33:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/"},"modified":"2026-06-16T08:33:50","modified_gmt":"2026-06-16T12:33:50","slug":"trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/","title":{"rendered":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale"},"content":{"rendered":"<p>        <!--.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale<\/b><\/p>\n<p><i>New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines.<\/i><\/p>\n<p>JUPITER, Fla.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nTriLink, part of Maravai LifeSciences\u00ae (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production.<\/p>\n<p><b>The launch addresses a long-standing pain point for RNA therapeutics developers sourcing<\/b> critical raw materials \u2014 enzymes, nucleotides, cap analogs, and tail technology \u2014 from multiple vendors with different quality systems, timelines, and points of contact. Managing different quality systems, timelines, and supply processes can slow development and create manufacturing risk. TriLink is now offering these materials as a coordinated, single-source package designed to simplify development and scale up.<\/p>\n<p><b>The Jupiter facility was purpose-built for GMP enzyme manufacturing<\/b>. It features controlled cleanroom environments, validated production processes, and scalable capacity designed to support both clinical-stage programs and commercial supply. Full traceability and quality systems are in place to meet regulatory requirements across major markets.<\/p>\n<p>\nThe facility is already supporting customer programs, with TriLink successfully shipping its first commercial GMP enzyme batch in June 2026. This milestone demonstrates the facility\u2019s operational readiness and ability to provide commercial-scale supply of critical IVT raw materials to RNA therapeutics developers worldwide.<\/p>\n<p><b>The facility\u2019s flagship product is GMP CleanScribe\u2122 RNA Polymerase that reduces double-stranded RNA (dsRNA) formation by up to 85%<\/b> compared to standard Wild-type T7 RNA polymerases, a result demonstrated across internal and customer studies. dsRNA is a critical quality attribute in therapeutic mRNA manufacturing: its accumulation drives purification complexity, depresses final RNA purity, and increases immunogenicity risk in vivo. CleanScribe\u2122 RNA Polymerase is engineered specifically for IVT workflows where controlling dsRNA at the synthesis step translates directly into downstream process efficiency and product quality.<\/p>\n<p><b>An Integrated IVT Raw Materials Solution<\/b><\/p>\n<p>\nTriLink BioTechnologies is now offering a coordinated supply of GMP-grade IVT raw materials:<\/p>\n<ul class=\"bwlistdisc\">\n<li><b>GMP CleanScribe\u2122 RNA Polymerase Mix<\/b><\/li>\n<li><b>GMP NTPs<\/b> (nucleoside triphosphates)\n<\/li>\n<li><b>GMP CleanCap\u00ae analogs<\/b> \u2014 the industry-standard co-transcriptional capping reagents\n<\/li>\n<li><b>GMP ModTail\u2122 technology<\/b> \u2014 designed to enhance mRNA stability and in vivo protein expression\n<\/li>\n<\/ul>\n<p>\nThe integrated offering is designed to reduce vendor complexity, simplify tech transfer, and ensure material consistency across the development lifecycle from IND-enabling studies through BLA submission and commercial launch.<\/p>\n<p>\nAs RNA-based therapeutics move into later-stage clinical development and commercial production, reliable access to manufacturing materials becomes increasingly important. Enzyme performance variability, regulatory gaps in supplier quality systems, and multi-vendor logistics create compounding delays at precisely the stages when speed matters most.<\/p>\n<p>\nCombining GMP manufacturing, high-performance enzyme design, and coordinated supply with TriLink\u2019s other GMP consumables, is intended to compress this complexity into a single, accountable partner relationship.<\/p>\n<p><i>\u201cRNA therapeutics developers need reliable supply partners that can support them from early research through commercial manufacturing. By combining enzyme manufacturing capabilities with TriLink\u2019s existing RNA technologies, we help customers simplify sourcing, reduce supply chain complexity, and accelerate scale-up with greater confidence.\u201d<\/i><\/p>\n<p><b>\u2014 Chad Decker, SVP Global Sales, TriLink BioTechnologies<\/b><\/p>\n<p>\nTo learn more about TriLink\u2019s new GMP enzyme capabilities visit: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.trilinkbiotech.com%2Fgmp-enzymes&amp;esheet=54554512&amp;newsitemid=20260616862149&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.trilinkbiotech.com%2Fgmp-enzymes&amp;index=1&amp;md5=4daac5da1f9a8a022c9a1d0abfcca970\">https:\/\/www.trilinkbiotech.com\/gmp-enzymes<\/a><\/p>\n<p><b>About TriLink BioTechnologies<\/b><\/p>\n<p>\nTriLink BioTechnologies, part of Maravai LifeSciences, is a global leader in nucleic acid technologies and manufacturing solutions for RNA therapeutics, vaccines, gene editing, and diagnostics. The company&#8217;s portfolio includes modified nucleotides, mRNA products, proprietary technologies such as CleanCap\u00ae capping analogs and ModTail\u2122 technology, and a growing portfolio of high-performance enzymes marketed under the Alphazyme brand. Supported by robust GMP manufacturing capabilities, TriLink enables customers from early-stage research through commercial production.<\/p>\n<p><b>About Maravai LifeSciences<\/b><\/p>\n<p>\nMaravai LifeSciences is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai\u2019s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world\u2019s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260616862149\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260616862149\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Contact:<br \/>\n<br \/>Deb Hart<br \/>\n<br \/>Maravai LifeSciences<br \/>\n<br \/>+1 858-988-5917<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@maravai.com\">ir@maravai.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Florida United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Genetics Research Pharmaceutical Science Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260616862149\/en\/2611206\/3\/Maravai_Logo_CMYK%5B29%5D-01.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla.&#8211;(BUSINESS WIRE)&#8211; TriLink, part of Maravai LifeSciences\u00ae (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. The launch addresses a long-standing pain point for RNA therapeutics developers sourcing critical raw materials \u2014 enzymes, nucleotides, cap analogs, and tail technology \u2014 from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-972564","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla.&#8211;(BUSINESS WIRE)&#8211; TriLink, part of Maravai LifeSciences\u00ae (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. The launch addresses a long-standing pain point for RNA therapeutics developers sourcing critical raw materials \u2014 enzymes, nucleotides, cap analogs, and tail technology \u2014 from &hellip; Continue reading &quot;TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-16T12:33:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale\",\"datePublished\":\"2026-06-16T12:33:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/\"},\"wordCount\":750,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/\",\"name\":\"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-06-16T12:33:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/","og_locale":"en_US","og_type":"article","og_title":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk","og_description":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale New Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. JUPITER, Fla.&#8211;(BUSINESS WIRE)&#8211; TriLink, part of Maravai LifeSciences\u00ae (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA therapeutic developers simplify sourcing and scale production more efficiently. The facility supports a coordinated supply of key RNA manufacturing and IVT workflow materials from early research through commercial production. The launch addresses a long-standing pain point for RNA therapeutics developers sourcing critical raw materials \u2014 enzymes, nucleotides, cap analogs, and tail technology \u2014 from &hellip; Continue reading \"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-16T12:33:50+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale","datePublished":"2026-06-16T12:33:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/"},"wordCount":750,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/","name":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-06-16T12:33:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260616862149r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trilink-opens-gmp-enzyme-manufacturing-facility-enabling-integrated-ivt-supply-from-rd-to-commercial-scale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&amp;D to Commercial Scale"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=972564"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/972564\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=972564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=972564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=972564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}